Patents by Inventor Yusuke Narita

Yusuke Narita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10989554
    Abstract: A computer-implemented method for controlling navigation includes generating an emotion data of a first user that illustrates emotion of the first user based on information received from a sensor. The method includes transmitting the emotion data of the first user to a controller configured to control a navigation of a second user. The first user and the second user are members of a same group. The method includes modifying the navigation of the second user according to the emotion data of the first user.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: April 27, 2021
    Assignee: Honda Motor Co., Ltd.
    Inventors: Takeshi Kitajima, Takao Fujiwara, Yoshitaka Suzuki, Kazuto Kawata, Wonravee Chavalit, Jenny Le, Ryan Lacross, Shigeyuki Seko, Shuhei Kinoshita, Yusuke Narita, Toshiaki Takano
  • Patent number: 10901416
    Abstract: This disclosure describes a vehicle system for identifying environmental objects within an operator's surroundings in a first window and removing object obstructions through a neural network in a second window to generate a rendered window, or scene, for display. As more windows are processed, the neural network may increase its understanding of the surroundings. The neural network may be a generative adversarial network (GAN) that may be trained to identify environmental objects by introducing noise data into those environmental objects. After receiving a first window from at least one camera on the vehicle, a rendered window may be created from a second window received from the at least one camera based on environmental objects identified within the first window through the GAN and removing object obstructions. The rendered window, without the object obstructions, and having superimposed environmental objects based on the GAN, may be displayed on an output device.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: January 26, 2021
    Assignee: Honda Motor Co., Ltd.
    Inventors: Rahul Khanna, Yusuke Narita
  • Publication number: 20200199689
    Abstract: The purpose of the present invention is to provide a method for predicting the effectiveness of an angiogenesis inhibitor in a subject suffering from a tumor. Provided is a method comprising a step of testing for the presence or absence of an a mutation or loss of expression of B-Raf and PTEN in a sample of tumor tissue from the subject. By using the presence or absence of or a mutation or loss of expression of B-Raf and PTEN as an indicator, this method enables the antitumor effectiveness of the angiogenesis inhibitor to be predicted without administering the angiogenesis inhibitor to the subject.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 25, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Taro Semba, Yusuke Narita, Yukinori Minoshima, Atsumi Yamaguchi, Yusuke Adachi, Kazuhiko Yamada, Junji Matsui, Tadashi Kadowaki, Kentaro Takahashi, Yasuhiro Funahashi
  • Publication number: 20200064146
    Abstract: A computer-implemented method for controlling navigation includes generating an emotion data of a first user that illustrates emotion of the first user based on information received from a sensor. The method includes transmitting the emotion data of the first user to a controller configured to control a navigation of a second user. The first user and the second user are members of a same group. The method includes modifying the navigation of the second user according to the emotion data of the first user.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 27, 2020
    Inventors: Takeshi Kitajima, Takao Fujiwara, Yoshitaka Suzuki, Kazuto Kawata, Wonravee Chavalit, Jenny Le, Ryan Lacross, Shigeyuki Seko, Shuhei Kinoshita, Yusuke Narita, Toshiaki Takano
  • Publication number: 20200026278
    Abstract: This disclosure describes a vehicle system for identifying environmental objects within an operator's surroundings in a first window and removing object obstructions through a neural network in a second window to generate a rendered window, or scene, for display. As more windows are processed, the neural network may increase its understanding of the surroundings. The neural network may be a generative adversarial network (GAN) that may be trained to identify environmental objects by introducing noise data into those environmental objects. After receiving a first window from at least one camera on the vehicle, a rendered window may be created from a second window received from the at least one camera based on environmental objects identified within the first window through the GAN and removing object obstructions. The rendered window, without the object obstructions, and having superimposed environmental objects based on the GAN, may be displayed on an output device.
    Type: Application
    Filed: July 19, 2018
    Publication date: January 23, 2020
    Inventors: Rahul KHANNA, Yusuke NARITA
  • Patent number: 10130579
    Abstract: A cosmetic material comprises (A) a hydrophobic powder; (B) a carboxylic acid modified silicone; (C) a basic compound; and (D) water. The (A) hydrophobic powder is generally dispersed in an aqueous phase of the cosmetic material. The cosmetic material can provide a refreshing sense of feel during use, and can form a cosmetic film with excellent water resistance on the skin.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: November 20, 2018
    Assignee: DOW CORNING TORAY CO., LTD.
    Inventors: Yuichi Kanaya, Jun Miyano, Akihiro Nakano, Yusuke Narita
  • Publication number: 20170191137
    Abstract: The purpose of the present invention is to provide a method for predicting the effectiveness of an angiogenesis inhibitor in a subject suffering from a tumor. Provided is a method comprising a step of testing for the presence or absence of an a mutation or loss of expression of B-Raf and PTEN in a sample of tumor tissue from the subject. By using the presence or absence of or a mutation or loss of expression of B-Raf and PTEN as an indicator, this method enables the antitumor effectiveness of the angiogenesis inhibitor to be predicted without administering the angiogenesis inhibitor to the subject.
    Type: Application
    Filed: March 16, 2017
    Publication date: July 6, 2017
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Taro Semba, Yusuke Narita, Yukinori Minoshima, Atsumi Yamaguchi, Yusuke Adachi, Kazuhiko Yamada, Junji Matsui, Tadashi Kadowaki, Kentaro Takahashi, Yasuhiro Funahashi
  • Publication number: 20170035681
    Abstract: A cosmetic material comprises (A) a hydrophobic powder; (B) a carboxylic acid modified silicone; (C) a basic compound; and (D) water. The (A) hydrophobic powder is generally dispersed in an aqueous phase of the cosmetic material. The cosmetic material can provide a refreshing sense of feel during use, and can form a cosmetic film with excellent water resistance on the skin.
    Type: Application
    Filed: April 8, 2015
    Publication date: February 9, 2017
    Inventors: Yuichi KANAYA, Jun MIYANO, Akihiro NAKANO, Yusuke NARITA
  • Patent number: 9129773
    Abstract: In many cases, the charged particle beam apparatus is used basically for observation at a magnification of 10,000 times or higher. It is thus difficult to recognize how the orientation of a sample seen with the naked eye corresponds to the origination of the sample appearing on an acquired image. This makes it difficult intuitively to grasp the tilt direction and other details of the sample. An object of this invention is to provide a charged particle beam apparatus allowing the orientation and the tilted state of the sample to be grasped intuitively.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: September 8, 2015
    Assignee: Hitachi High-Technologies Corporation
    Inventors: Tohru Ando, Kunji Shigeto, Shotaro Tamayama, Yusuke Narita
  • Publication number: 20150144804
    Abstract: In many cases, the charged particle beam apparatus is used basically for observation at a magnification of 10,000 times or higher. It is thus difficult to recognize how the orientation of a sample seen with the naked eye corresponds to the origination of the sample appearing on an acquired image. This makes it difficult intuitively to grasp the tilt direction and other details of the sample. An object of this invention is to provide a charged particle beam apparatus allowing the orientation and the tilted state of the sample to be grasped intuitively.
    Type: Application
    Filed: June 3, 2013
    Publication date: May 28, 2015
    Inventors: Tohru Ando, Kunji Shigeto, Shotaro Tamayama, Yusuke Narita
  • Patent number: 8962650
    Abstract: A therapeutic agent for tumor for combined use of a compound or pharmaceutically acceptable salt thereof represented by Formula (I) and a compound represented by Formula (II): wherein R1 is C1-6 alkyl or C3-8 cycloalkyl, R2 is a hydrogen atom or C1-6 alkoxy, and R3 is a hydrogen atom or a halogen atom, exhibits an excellent antitumor effect compared to cases where these are individually used.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: February 24, 2015
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Yusuke Narita, Junji Matsui, Yasuhiro Funahashi
  • Publication number: 20140148483
    Abstract: The purpose of the present invention is to provide a method for predicting the effectiveness of an angiogenesis inhibitor in a subject suffering from a tumor. Provided is a method comprising a step of testing for the presence or absence of an a mutation or loss of expression of B-Raf and PTEN in a sample of tumor tissue from the subject. By using the presence or absence of or a mutation or loss of expression of B-Raf and PTEN as an indicator, this method enables the antitumor effectiveness of the angiogenesis inhibitor to be predicted without administering the angiogenesis inhibitor to the subject.
    Type: Application
    Filed: May 16, 2012
    Publication date: May 29, 2014
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Taro Semba, Yusuke Narita, Yukinori Minoshima, Atsumi Yamaguchi, Yusuke Adachi, Kazuhiko Yamada, Junji Matsui, Tadashi Kadowaki, Kentaro Takahashi, Yasuhiro Funahashi
  • Publication number: 20140031384
    Abstract: A therapeutic agent for tumor for combined use of a compound or pharmaceutically acceptable salt thereof represented by Formula (I) and a compound represented by Formula (II): wherein R1 is C1-6 alkyl or C3-8 cycloalkyl, R2 is a hydrogen atom or C1-6 alkoxy, and R3 is a hydrogen atom or a halogen atom, exhibits an excellent antitumor effect compared to cases where these are individually used.
    Type: Application
    Filed: April 16, 2012
    Publication date: January 30, 2014
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Yusuke Narita, Junji Matsui, Yasuhiro Funahashi
  • Patent number: 6610987
    Abstract: In order to suppress quick potential change on the surface of a process target when the shutter plate is opened and closed, when an ion beam IB from the ion source 10 is irradiated on a substrate 38 and the ion beam IB is neutralized by using neutralizing electrons e− generated by a microwave neutralizer 14, the shutter plate 62 shields the substrate 38 before and after the milling processing of the substrate 38, and the voltage of a power supply 34 is lowered when the shutter plate 62 is opened and closed so as to limit the amount of ion beam IB irradiation, thereby suppressing charge-up on the surface of the substrate 38.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: August 26, 2003
    Assignee: Hitachi, Ltd.
    Inventors: Yoshihiro Kimura, Ko Hisamoto, Takaharu Sugiura, Yusuke Narita
  • Publication number: 20020175296
    Abstract: In order to suppress quick potential change on the surface of a process target when the shutter plate is opened and closed, when an ion beam IB from the ion source 10 is irradiated on a substrate 38 and the ion beam IB is neutralized by using neutralizing electrons e− generated by a microwave neutralizer 14, the shutter plate 62 shields the substrate 38 before and after the milling processing of the substrate 38, and the voltage of a power supply 34 is lowered when the shutter plate 62 is opened and closed so as to limit the amount of ion beam IB irradiation, thereby suppressing charge-up on the surface of the substrate 38.
    Type: Application
    Filed: February 25, 2002
    Publication date: November 28, 2002
    Inventors: Yoshihiro Kimura, Ko Hisamoto, Takaharu Sugiura, Yusuke Narita